[{"address1": "2617 Bissonnet Street", "address2": "Suite 225", "city": "Houston", "state": "TX", "zip": "77005", "country": "United States", "phone": "346 355 4099", "website": "https://www.alaunos.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive T-cell receptor (TCR) engineered T-cell therapies (TCR-T) to treat multiple solid tumor types. It develops Library TCR-T Cell Theraphy, which is in Phase I/II clinical trial for 12 TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancreatic, ovarian, and bile duct cancers. The company is also developing hunTR, a human neoantigen TCR discovery engine; and Sleeping Beauty Gene Transfer Platform, a non-viral genetic engineering technology. The company was founded in 2003 and is headquartered in Houston, Texas.", "fullTimeEmployees": 1, "companyOfficers": [{"maxAge": 1, "name": "Mr. Dale Curtis Hogue Jr.", "age": 54, "title": "Interim CEO & Director", "yearBorn": 1970, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Melinda  Lackey", "age": 47, "title": "Senior VP of Legal, Administration & Secretary", "yearBorn": 1977, "fiscalYear": 2023, "totalPay": 625117, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 6, "compensationRisk": 9, "shareHolderRightsRisk": 3, "overallRisk": 7, "governanceEpochDate": 1740787200, "compensationAsOfEpochDate": 1703980800, "irWebsite": "http://ir.ziopharm.com/index.cfm", "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.5, "open": 1.4349, "dayLow": 1.4349, "dayHigh": 1.4349, "regularMarketPreviousClose": 1.5, "regularMarketOpen": 1.4349, "regularMarketDayLow": 1.4349, "regularMarketDayHigh": 1.4349, "payoutRatio": 0.0, "beta": -0.528, "forwardPE": -2.3915, "volume": 510, "regularMarketVolume": 510, "averageVolume": 17743, "averageVolume10days": 9520, "averageDailyVolume10Day": 9520, "bid": 1.2, "ask": 1.71, "bidSize": 1, "askSize": 1, "marketCap": 2297633, "fiftyTwoWeekLow": 1.42, "fiftyTwoWeekHigh": 20.3, "priceToSalesTrailing12Months": 328.23328, "fiftyDayAverage": 1.6576, "twoHundredDayAverage": 3.23125, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 690215, "profitMargins": 0.0, "floatShares": 1534704, "sharesOutstanding": 1601250, "sharesShort": 59065, "sharesShortPriorMonth": 65738, "sharesShortPreviousMonthDate": 1738281600, "dateShortInterest": 1740700800, "sharesPercentSharesOut": 0.0369, "heldPercentInsiders": 0.14109999, "heldPercentInstitutions": 0.045100003, "shortRatio": 6.06, "shortPercentOfFloat": 0.0429, "impliedSharesOutstanding": 1601250, "bookValue": 1.701, "priceToBook": 0.84356266, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -11780000, "trailingEps": -315.39, "forwardEps": -0.6, "lastSplitFactor": "1:10", "lastSplitDate": 1721260800, "enterpriseToRevenue": 98.602, "enterpriseToEbitda": -0.096, "52WeekChange": -0.91731846, "SandP52WeekChange": 0.07465422, "quoteType": "EQUITY", "currentPrice": 1.4349, "recommendationKey": "none", "totalCash": 1683000, "totalCashPerShare": 1.051, "ebitda": -7173000, "totalDebt": 0, "quickRatio": 2.038, "currentRatio": 4.298, "totalRevenue": 7000, "revenuePerShare": 0.004, "returnOnAssets": -0.40327, "returnOnEquity": -1.4172301, "grossProfits": -1374000, "freeCashflow": -8272625, "operatingCashflow": -11764000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -1059.5714, "financialCurrency": "USD", "symbol": "TCRT", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Alaunos Therapeutics, Inc.", "longName": "Alaunos Therapeutics, Inc.", "corporateActions": [], "regularMarketTime": 1742408757, "exchange": "NCM", "messageBoardId": "finmb_11686323", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -4.339997, "regularMarketPrice": 1.4349, "marketState": "REGULAR", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1124890200000, "regularMarketChange": -0.065099955, "regularMarketDayRange": "1.4349 - 1.4349", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 17743, "fiftyTwoWeekLowChange": 0.014900088, "fiftyTwoWeekLowChangePercent": 0.0104930205, "fiftyTwoWeekRange": "1.42 - 20.3", "fiftyTwoWeekHighChange": -18.865099, "fiftyTwoWeekHighChangePercent": -0.92931527, "fiftyTwoWeekChangePercent": -91.73185, "earningsTimestampStart": 1743424200, "earningsTimestampEnd": 1743769800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -315.39, "epsForward": -0.6, "fiftyDayAverageChange": -0.2227, "fiftyDayAverageChangePercent": -0.13435087, "twoHundredDayAverageChange": -1.79635, "twoHundredDayAverageChangePercent": -0.5559304, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "ZIOPHARM Oncology, Inc.", "nameChangeDate": "2025-03-18", "cryptoTradeable": false, "displayName": "Alaunos Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-03-19"}]